| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3df26a4f1113ee584fd7f82aa7095fec |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-11031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0823
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-00 |
| filingDate |
2008-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f412be03acaaecbf4fb87dcc0f7c46fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4e191c96e679c311fe6976710d324b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59e9f668434a835af36974873624a79f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42da79af8b9fb96594a1825ebeaa5d12 |
| publicationDate |
2010-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20100018632-A |
| titleOfInvention |
Peptides having AMPK activity |
| abstract |
The present invention relates to a peptide having AMPK activity, and more particularly, to a peptide containing Pro-Gly as an active ingredient and having AMPK activity, and more particularly to a peptide having an anti-obesity and anti-diabetic effect.n n n The peptide having an amino acid sequence comprising Pro-Gly according to the present invention may have anti-obesity and anti-diabetic effects by promoting energy metabolism of AMPK activity of skeletal muscle cells. The physiological and pharmacological effects of the peptide having an amino acid sequence including Pro-Gly can be developed as a dietary supplement for treating obesity and diabetes as well as for treating obesity and diabetes. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108884131-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108884131-A |
| priorityDate |
2008-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |